Login / Signup

Author Correction: A phase I clinical trial for [ 131 I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma.

Hiroshi WakabayashiAnri InakiKenichi YoshimuraToshinori MurayamaYasuhito ImaiTetsuya HiguchiMegumi JingujiTohru ShigaSeigo Kinuya
Published in: Scientific reports (2022)
Keyphrases
  • clinical trial
  • phase ii
  • open label
  • study protocol
  • double blind
  • stem cells
  • randomized controlled trial
  • phase iii
  • cell therapy
  • bone marrow